News & Updates
Search Research Content
Resource Finder at Kennedy Krieger Institute
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes.
|Title||In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes.|
|Publication Type||Journal Article|
|Year of Publication||2009|
|Authors||Witter FR, Zimmerman AW, Reichmann JP, Connors SL|
|Journal||American journal of obstetrics and gynecology|
|Date Published||2009 Dec|
Beta 2 adrenergic receptor overstimulation during critical periods of prenatal development can induce a permanent shift in the balance of sympathetic-to-parasympathetic tone. This is a biologically plausible mechanism whereby beta 2 adrenergic agonists can induce functional and behavioral teratogenesis, which explains their association with increases in autism spectrum disorders, psychiatric disorders, poor cognitive, motor function and school performance, and changes in blood pressure in the offspring. The use of beta 2 adrenergic agonists should be limited to proven indications when alternate drugs are ineffective or unavailable; the risks of untreated disease to the mother and fetus are greater than the risk of the beta 2 adrenergic agonist.
|Alternate Journal||Am. J. Obstet. Gynecol.|